(Bold for FDA approved)
How LOFLAZEPATE works• Binds to benzodiazepine receptors at the GABA-A ligand-gated chloride channel complex
• Enhances the inhibitory effects of GABA
• Boosts chloride conductance through GABA-regulated channels
• Inhibits neuronal activity presumably in amygdala-centered fear circuits to provide therapeutic benefits in anxiety disorders
• Some immediate relief with first dosing is common; can take several weeks with daily dosing for maximal therapeutic benefit
Notable Side Effects• Sedation, fatigue, depression
• Dizziness, ataxia, slurred speech, weakness
• Forgetfulness, confusion
• Hyperexcitability, nervousness
• Rare hallucinations, mania
• Rare hypotension
• Hypersalivation, dry mouth
Life Threatening Side Effects• Respiratory depression, especially when taken with CNS depressants in overdose
• Rare hepatic dysfunction, renal dysfunction, blood dyscrasias

unusual

not usual
• Wait
• Wait
• Wait
• Lower the dose
• Take largest dose at bedtime to avoid sedative effects during the day
• Switch to another agent
• Administer flumazenil if side effects are severe or life-threatening
• 1 mg once or twice a day
Dosage Forms• Tablet 1 mg, 2 mg
• Risk of dependence, particularly for treatment periods longer than 12 weeks and especially in patients with past or current polysubstance abuse
• Patients may develop dependence and/or tolerance with long-term use
Renal Impairment• Drug should be used with caution
Hepatic Impairment• Drug should be used with caution
Cardiac Impairment• Benzodiazepines have been used to treat anxiety associated with acute myocardial infarction
Elderly• Drug should be used with caution
• Should begin with lower starting dose
Children and Adolescents• Safety and efficacy have not been established
• Benzodiazepines are often used in children and adolescents, especially short-term and at the lower end of the dosing scale
• Long-term effects of loflazepate in children/ adolescents are unknown
• Should generally receive lower doses and be more closely monitored
PregnancyPossible increased risk of birth defects when benzodiazepines are taken during pregnancy
• Because of the potential risks, loflazepate is not generally recommended as treatment for anxiety during pregnancy, especially during first trimester
• Drug should be tapered if discontinued
• Infants whose mothers received a benzodiazepine late in pregnancy may experience withdrawal effects
• Neonatal flaccidity has been reported in infants whose mothers took a benzodiazepine during pregnancy
• Seizures, even mild seizures, may cause harm to the embryo/fetus
Breast Feeding• Some drug is found in mother’s breast milk
• Recommended either to discontinue drug or bottle feed
• Effects on infant have been observed and include feeding difficulties, sedation, and weight loss
Based on data Published online by Cambridge University Press
Compiled by Dr. Jash Ajmera